Evidence map›Paper›PMID 34340689›Full record

ArticleBMC infectious diseases2021

HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.

Adwoa K A Afrane, Bamenla Q Goka, Lorna Renner, Alfred E Yawson, Yakubu Alhassan, Seth N Owiafe, Seth Agyeman, Kwamena W C Sagoe, Awewura Kwara

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Adwoa K A AfraneDepartment of Child Health, Korle Bu Teaching Hospital, Accra, Ghana. dadwoa@yahoo.com.
Bamenla Q GokaDepartment of Child Health, Korle Bu Teaching Hospital, Accra, Ghana.
Lorna RennerDepartment of Child Health, Korle Bu Teaching Hospital, Accra, Ghana.
Alfred E YawsonDepartment of Community Health, University of Ghana Medical School, Legon, Accra, Ghana.
Yakubu AlhassanDepartment of Health Policy Planning and Management, School of Public Health, University of Ghana, Legon, Accra, Ghana.
Seth N OwiafeDepartment of Child Health, Korle Bu Teaching Hospital, Accra, Ghana.
Seth AgyemanDepartment of Immunology, Korle Bu Teaching Hospital, Accra, Ghana.
Kwamena W C SagoeDepartment of Medical Microbiology, University of Ghana Medical School, Accra, Ghana.
Awewura KwaraDepartment of Medicine, University of Florida, College of Medicine, Gainesville, Florida, USA.
Korle Bu Teaching Hospital · GHUniversity of Ghana · GHUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChildren living with human immunodeficiency virus (HIV) infection require lifelong effective antiretroviral therapy (ART). The goal of ART in HIV-infected persons is sustained viral suppression. There is limited information on virological non-suppression or failure and its associated factors in children in resource limited countries, particularly Ghana.

methodsA cross-sectional study of 250 children aged 8 months to 15 years who had been on ART for at least 6 months attending the Paediatric HIV clinic at Korle Bu Teaching hospital in Ghana was performed. Socio-demographic, clinical, laboratory and ART Adherence related data were collected using questionnaires as well as medical records review. Blood samples were obtained for viral load and CD4

resultsThe mean (±SD) age of the study participants was 11.4 ± 2.4 years and the proportion of males was 53.2%. Of the 250 study participants, 96 (38.4%) had virological non-suppression. After adjustment for significant variables, the factors associated with non-suppressed viral load were female gender (AOR 2.51 [95% CI 1.04-6.07], p = 0.041), having a previous history of treatment of tuberculosis (AOR 4.95 [95% CI 1.58-15.5], p = 0.006), severe CD4 immune suppression status at study recruitment (AOR 24.93 [95% CI 4.92-126.31], p < 0.001) and being on a nevirapine (NVP) based regimen (AOR 7.93 [95% CI 1.58-1.15], p = 0.005).

conclusionThe prevelance of virological non-suppression was high. Virological non-suppression was associated with a previous history of TB treatment, female gender, severe CD4 immune suppression status at study recruitment and being on a NVP based regimen. Early initiation of ART and phasing out NVP-based regimen might improve viral load suppression in children. In addition, children with a history of TB may need focused measures to maximize virological suppression.

Indexed as

AdolescentAnti-HIV AgentsCD4 Lymphocyte CountChildChild, PreschoolCross-Sectional StudiesFemaleGhanaHIVHIV InfectionsHumansInfantLogistic ModelsMaleNevirapineRisk FactorsAnti-HIV AgentsNevirapineAntiretroviral therapyPaediatric HIVViral loadVirological non-suppression

Identifiers

PMID34340689
PMCPMC8330060
OpenAlexW3159611925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.